Device for gaseous plasma sterilization

Details for Australian Patent Application No. 2005321172 (hide)

Owner Societe Pour La Conception Des Applications Des Techniques Electroniques

Inventors Regere, Pascal; Ricard, Andre; Cousty, Sarah

Agent Griffith Hack

Pub. Number AU-B-2005321172

PCT Pub. Number WO2006/070107

Priority 0413818 23.12.04 FR

Filing date 21 December 2005

Wipo publication date 6 July 2006

Acceptance publication date 28 April 2011

International Classifications

H05H 1/46 (2006.01) Generating plasma - using applied electromagnetic fields, e.g. high frequency or microwave energy

H01J 37/32 (2006.01) Discharge tubes with provision for introducing objects or material to be exposed to the discharge, e.g. for the purpose of examination or processing thereof - Gas-filled discharge tubes

H05B 6/68 (2006.01) Heating by electric, magnetic, or electromagnetic fields - for monitoring or control

Event Publications

19 July 2007 PCT application entered the National Phase

  PCT publication WO2006/070107 Priority application(s): WO2006/070107

1 May 2008 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read Regere, Pascal; Ricard, Andre and Cousty, Sarah

7 April 2011 Alteration of Name

  The name of the applicant has been altered to Societe Pour La Conception Des Applications Des Techniques Electroniques 2006

28 April 2011 Application Accepted

  Published as AU-B-2005321172

25 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005321182-Novel galenic system for active principle transport, preparation method and use

2005321171-N-[(4, 5-diphenyl-3-alkyl-2-thienyl) methyl] amine (amide, sulfonamide, carbamate and urea) derivatives as cannabinoid CB1 receptor antagonists